Skip to main content
. 2020 Jul 27;24:461. doi: 10.1186/s13054-020-03147-3

Fig. 1.

Fig. 1

PCA analysis of DI-MS/MS day 1 plasma metabolites comparing non-survivors (n = 75) to survivors (n = 75) of bacterial CAP patients. The cumulative R2X = 0.554 showed a high variability between two cohorts